These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 31588184)
1. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma. Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184 [No Abstract] [Full Text] [Related]
2. The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma. Shioya A; Guo X; Motono N; Mizuguchi S; Kurose N; Nakada S; Aikawa A; Ikeda Y; Uramoto H; Yamada S Int J Med Sci; 2018; 15(10):1025-1034. PubMed ID: 30013444 [No Abstract] [Full Text] [Related]
3. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047 [No Abstract] [Full Text] [Related]
4. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma. Lu GS; Li M; Xu CX; Wang D Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076 [TBL] [Abstract][Full Text] [Related]
5. Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis. Lou Y; Xu J; Zhang Y; Zhang W; Zhang X; Gu P; Zhong H; Wang H; Lu J; Han B Cell Death Dis; 2021 Feb; 12(2):170. PubMed ID: 33568630 [TBL] [Abstract][Full Text] [Related]
6. Potential Impacts of Lee KL; Lai TC; Wang YC; Shih PC; Yang YC; Tsao TC; Liu TC; Wen YC; Chang LC; Yang SF; Chien MH Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802737 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma. Wang F; Zhao N; Gao G; Deng HB; Wang ZH; Deng LL; Yang Y; Lu C J Cancer Res Clin Oncol; 2020 Nov; 146(11):2851-2859. PubMed ID: 32743759 [TBL] [Abstract][Full Text] [Related]
8. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma. Mao Y; Xu R Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486 [TBL] [Abstract][Full Text] [Related]
9. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma. Hu HB; Yang XP; Zhou PX; Yang XA; Yin B Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767 [TBL] [Abstract][Full Text] [Related]
10. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma. Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
12. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor. Yu L; Qiao R; Xu J; Han B; Zhong R Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ Gene; 2020 Mar; 730():144316. PubMed ID: 31884109 [TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival. Li T; Liu J; Zhou Y; Huang S; Wang D; Chen J; Fu Y; He P Cancer Med; 2024 May; 13(10):e7227. PubMed ID: 38770632 [TBL] [Abstract][Full Text] [Related]
16. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma. Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818 [TBL] [Abstract][Full Text] [Related]
17. HIF-1α-HPRT1 axis promotes tumorigenesis and gefitinib resistance by enhancing purine metabolism in EGFR-mutant lung adenocarcinoma. Geng P; Ye F; Dou P; Hu C; He J; Zhao J; Li Q; Bao M; Li X; Liu X; Xu G J Exp Clin Cancer Res; 2024 Sep; 43(1):269. PubMed ID: 39343971 [TBL] [Abstract][Full Text] [Related]
18. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway. Zhang H; Cao Y; Tang J; Wang R Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530 [TBL] [Abstract][Full Text] [Related]
20. Elevated Expression of Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]